Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kyverna Therapeutics, Inc. (KYTX) since 2024 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kyverna Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1994702.
Total stock buying since 2024: $45,388,992.
Total stock sales since 2024: $0.
Total stock option exercises since 2024: $55,742.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 2,063,136 | $45,388,992 | 0 | $0 | 27,652 | $55,742 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-06 | 0 | $0 | 0 | $0 | 9,636 | $42,591 |
| 2024-05 | 0 | $0 | 0 | $0 | 18,016 | $13,151 |
| 2024-02 | 2,063,136 | $45,388,992 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-06-06 | Walker Karen Marie (Chief Technology Officer) | Option Ex | 9,636 | 4.42 | 42,591 |
| 2024-05-28 | Jones Ryan Alexander (Chief Financial Officer) | Option Ex | 18,016 | .73 | 13,151 |
| 2024-02-12 | Bain Capital Life Sciences Opportunities Iii, Lp | Buy | 450,000 | 22.00 | 9,900,000 |
| 2024-02-12 | Rubin Michael P. | Buy | 450,000 | 22.00 | 9,900,000 |
| 2024-02-12 | Vida Ventures Iii-a, L.p. | Buy | 253,136 | 22.00 | 5,568,992 |
| 2024-02-12 | Gilead Sciences, Inc. (10% Owner) | Buy | 910,000 | 22.00 | 20,020,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of KYTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kyverna Therapeutics, Inc. (symbol KYTX, CIK number 1994702) see the Securities and Exchange Commission (SEC) website.